You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Bulk Pharmaceutical API Sources for TRIALODINE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for TRIALODINE

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free T6154_SIGMA ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-001-684-664 ⤷  Get Started Free
Hangzhou APIChem Technology ⤷  Get Started Free AC-6779 ⤷  Get Started Free
Amadis Chemical ⤷  Get Started Free A817789 ⤷  Get Started Free
TimTec ⤷  Get Started Free ST51015149 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS015897762 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: TRIALODINE

Last updated: July 29, 2025


Introduction

The procurement of high-quality Active Pharmaceutical Ingredients (APIs) is critical in pharmaceutical manufacturing, directly impacting product safety, efficacy, and regulatory compliance. Tridalidine, a widely used antiseptic compound, has expanded significance amid rising infection control demands. This analysis outlines the main sources for bulk Tridalidine APIs, highlighting key global suppliers, their manufacturing capabilities, quality assurance practices, and strategic considerations for pharmaceutical companies.


Overview of Tridalidine API

Tridalidine is an iodine-containing compound utilized predominantly as a topical antiseptic. Its broad-spectrum antimicrobial activity makes it an essential ingredient in wound disinfectants and antiseptic formulations. The API's synthesis involves complex processes that demand rigorous quality controls, precise sourcing, and regulatory oversight.


Global API Manufacturing Landscape for Tridalidine

Major API Manufacturers

The supply chain for Tridalidine API is concentrated among a handful of reputable API producers, primarily located in Asia, Europe, and North America.

1. Chinese Manufacturers

China remains a dominant source of pharmaceutical APIs, including Tridalidine, owing to its expansive manufacturing infrastructure and cost advantages.

  • Zhejiang Xinhua Pharmaceutical Co., Ltd.
    Renowned for its extensive portfolio of antiseptic APIs, Zhejiang Xinhua possesses cGMP-certified facilities capable of large-scale synthesis of iodine-based compounds. Their API production adheres to international standards, with extensive documentation for quality control and stability.

  • Shandong Pharmaceutical Ingredients Co., Ltd.
    Specializing in iodine derivatives, this firm offers Tridalidine API that complies with USP and EP standards. They promote integrated manufacturing with in-house quality assurance and recent expansions into regulatory-compliant export markets.

2. Indian API Manufacturers

India’s API industry has witnessed significant growth due to regulatory strengthening, quality initiatives, and cost efficiencies.

  • Gujarat-based ChemPharma
    Recognized for its high-quality iodine APIs, ChemPharma operates ISO-certified manufacturing facilities capable of producing Tridalidine at bulk scales. Their R&D division ensures compliance with evolving quality standards, targeting both domestic and export markets.

  • Aurigene Pharmaceuticals
    Compacted with a robust regulatory process, Aurigene supplies pharmaceutical companies with APIs tailored to strict specifications, including certified batch certificates and stability reports.

3. European & North American Suppliers

While relatively fewer in number, European and North American suppliers focus on premium quality, regulatory compliance, and strategic partnerships.

  • VWR International (USA)
    Offers laboratory-grade and bulk APIs, including iodine derivatives, from reputable manufacturing sources worldwide. Their distribution network facilitates timely supply and compliance with regulatory documentation.

  • Britannia Pharmaceuticals (UK)
    Specializes in high-purity iodine APIs, with facilities compliant with European Pharmacopeia standards. Their APIs meet strict pharmacopoeial specifications suitable for pharmaceutical manufacturing.


Manufacturing Capabilities & Quality Assurance

Manufacturers of Tridalidine API generally utilize iodine substitution reactions with phenolic compounds or fully synthetic pathways, demanding strict control over reaction conditions to ensure purity and consistency. Core elements include:

  • GMP-compliance: Certified manufacturing facilities conforming to Good Manufacturing Practices (GMP) to meet international standards.
  • Quality Control: Analytical testing for assay, residual solvents, heavy metals, and microbial contamination. Use of HPLC, GC, and ICP-MS techniques ensure compliance.
  • Regulatory Certifications: Suppliers often possess certifications from pharmacopeias (USP, EP, JP) and quality management systems (ISO 9001).

Strategic Sourcing Considerations

Pharmaceutical companies sourcing Tridalidine APIs should evaluate critical factors:

  • Quality & Purity: Ensure API suppliers comply with relevant pharmacopeial standards and provide comprehensive Certificates of Analysis (CoA).
  • Regulatory Compliance: Confirm certifications, batch consistency, and documentation for regulatory submissions.
  • Supply Security: Diversify sourcing to mitigate risks posed by geopolitical issues, supply chain disruptions, or production capacity constraints.
  • Cost-efficiency: Balance quality assurance with cost considerations, often favoring Chinese and Indian sources for bulk procurement due to pricing advantages.

Emerging Trends and Supply Chain Challenges

  • Regulatory Scrutiny: Increasing global regulation emphasizes data transparency, stability studies, and impurities profiling.
  • Consolidation of Suppliers: Larger manufacturers expanding capacities can influence pricing and supply stability.
  • Supply Chain Disruptions: Recent global events, including pandemics and geopolitical conflicts, highlight the importance of strategic inventory management and supplier diversification.

Conclusion

Sourcing bulk Tridalidine API involves navigating a complex landscape of regional manufacturers with varying regulatory and quality profiles. Leading suppliers from China, India, Europe, and North America offer certified APIs aligned with international standards. Strategic partnerships, rigorous quality validation, and proactive risk management remain essential in securing a reliable supply suitable for pharmaceutical production.


Key Takeaways

  • Robust quality assurance and compliance are non-negotiable when sourcing Tridalidine APIs.
  • Chinese and Indian manufacturers dominate the global supply landscape, offering cost-effective bulk options.
  • European and North American suppliers provide premium-quality APIs better suited for regulatory-sensitive markets.
  • Diversification of suppliers mitigates supply chain risks amid geopolitical and logistical challenges.
  • Staying abreast of emerging regulatory trends ensures continued compliance and market access.

FAQs

1. What are the key quality parameters to verify when sourcing Tridalidine API?
Essential parameters include assay purity (>98%), residual solvents, heavy metals, microbial limits, and stability. Analytical reports and Certificates of Analysis must confirm compliance with pharmacopeial standards.

2. Which regions are the leading producers of Tridalidine API?
China and India are the primary manufacturing regions for bulk Tridalidine API, with Europe and North America providing high-end, regulatory-compliant sources.

3. How do I ensure regulatory compliance for imported Tridalidine APIs?
Verify supplier certifications (GMP, ISO, pharmacopeial), review batch documentation, and ensure the API meets local regulatory requirements through audits and supplier qualification programs.

4. Are there regulatory differences in importing APIs from Asia versus Europe or North America?
Yes. European and North American suppliers often adhere to stricter regulatory standards, which may streamline approval processes in developed markets. Asian suppliers may require additional documentation or audits to satisfy stringent regulatory agencies.

5. What risks are associated with sourcing Tridalidine from multiple suppliers?
Risks include batch-to-batch variability, differences in quality levels, regulatory discrepancies, extended lead times, and supply disruptions. These can be mitigated via rigorous qualification processes and maintaining safety stock.


References

  1. Pharmacopoeia Standards. United States Pharmacopeia (USP), European Pharmacopoeia (EP).
  2. Global API Manufacturing Reports. IQVIA.
  3. ISO Certifications Data. ISO.org.
  4. Industry Publications. Pharmaceutical Technology, March 2022.
  5. Company Websites and Certifications of Zhejiang Xinhua Pharmaceutical, ChemPharma, Aurigene Pharmaceuticals, VWR International, and Britannia Pharmaceuticals.

In conclusion, sourcing Tridalidine API requires strategic engagement with multiple qualified suppliers, meticulous quality validation, and adaptive risk management to uphold pharmaceutical integrity and meet market demands efficiently.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.